11-02-2025
Novonesis to buy DSM-Firmenich's stake in enzymes venture for $1.6 bln
COPENHAGEN, Feb 11 (Reuters) - Denmark's Novonesis ( opens new tab said on Tuesday that it had agreed to buy the stake of its partner, Swiss-Dutch chemical manufacturer DSM-Firmenich, in their joint enzymes venture for 1.5 billion euros ($1.55 billion).
Get the latest news and expert analysis about the state of the global economy with the Reuters Econ World newsletter. Sign up here.
Reporting by Stine Jacobsen, editing by Terje Solsvik
